To further our understanding of the unresponsiveness of TAb2 tumors to anti-PD-L1 treatment, we performed transcriptional analysis by bulk RNA sequencing (RNA-Seq) using tumor RNA samples to identify potential tumor-intrinsic factors that may contribute to an immunosuppressive TME of TAb2 tumors. This evidence concerns the gene CD274 and neoplasm.